PSMA3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.810200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.767400E-01
Normal-vs-Stage2
6.889400E-01
Normal-vs-Stage3
7.348400E-01
Normal-vs-Stage4
9.427200E-01
Stage1-vs-Stage2
1.575750E-01
Stage1-vs-Stage3
9.152800E-01
Stage1-vs-Stage4
6.701800E-01
Stage2-vs-Stage3
3.160400E-01
Stage2-vs-Stage4
5.727000E-01
Stage3-vs-Stage4
8.039800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.553000E-01
Normal-vs-AfricanAmerican
8.391200E-01
Normal-vs-Asian
9.467400E-01
Caucasian-vs-AfricanAmerican
4.489600E-01
Caucasian-vs-Asian
6.516400E-01
AfricanAmerican-vs-Asian
7.330600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.015800E-01
Normal-vs-Female
7.474600E-01
Male-vs-Female
7.748000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.984800E-01
Normal-vs-Age(41-60Yrs)
4.474000E-01
Normal-vs-Age(61-80Yrs)
9.384800E-01
Normal-vs-Age(81-100Yrs)
4.020600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.395220E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.963000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.122800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.982100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.860400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.388000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.954200E-01
Normal-vs-Daily Drinker
7.334200E-01
Normal-vs-Weekly Drinker
8.074800E-01
Normal-vs-Occasional Drinker
4.108000E-01
Normal-vs-Social Drinker
7.639600E-01
Non Drinker-vs-Daily Drinker
4.522200E-01
Non Drinker-vs-Weekly Drinker
6.508200E-01
Non Drinker-vs-Occasional Drinker
1.853980E-01
Non Drinker-vs-Social Drinker
6.612400E-01
Daily Drinker-vs-Weekly Drinker
3.139800E-01
Daily Drinker-vs-Occasional Drinker
6.515000E-01
Daily Drinker-vs-Social Drinker
6.741200E-01
Weekly Drinker-vs-Occasional Drinker
9.724100E-02
Weekly Drinker-vs-Social Drinker
3.980200E-01
Occasional Drinker-vs-Social Drinker
2.750600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.320200E-01
Normal-vs-Grade 2
8.103600E-01
Normal-vs-Grade 3
7.532200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.556100E-02
Grade 1-vs-Grade 3
1.373830E-02
Grade 1-vs-Grade 4
9.320200E-01
Grade 2-vs-Grade 3
2.627000E-01
Grade 2-vs-Grade 4
8.103600E-01
Grade 3-vs-Grade 4
7.532200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.504400E-01
Normal-vs-NonDiabetic
8.036600E-01
Diabetic-vs-NonDiabetic
5.872400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.290800E-01
Normal-vs-NoPancreatitis
8.120400E-01
Pancreatitis-vs-NoPancreatitis
4.110000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.993200E-01
Normal-vs-N1
7.055200E-01
N0-vs-N1
2.013600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.054200E-01
Normal-vs-TP53-NonMutant
8.071600E-01
TP53-Mutant-vs-TP53-NonMutant
2.55480000044273E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
